Quantification of renal perfusion using an intravascular contrast agent (part 1): Results in a canine model

Magnetic Resonance in Medicine

Volumn 49, Issue 2, 2003, Pages 276-287

  Aumann, Silke ^a   Schoenberg, Stefan O ^a,e   Just, Armin ^b   Briley Saebo, Karen ^c   Bjørnerud, Atle ^c   Bock, Michael ^a   Brix, Gunnar ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Amersham Health   (Norway)

^d BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dynamic T*2 weighted imaging; Intravascular contrast agent; Kidney; Perfusion; Susceptibility contrast; Time series deconvolution

Indexed keywords

HEMODYNAMICS; MAGNETIC SUSCEPTIBILITY; NANOCOMPOSITES; PROBES;

ARTERIAL INPUT FUNCTION; CONTRAST AGENT; DECONVOLUTION ANALYSIS; DYNAMIC SUSCEPTIBILITY; INDICATOR-DILUTION THEORY; KIDNEY; PERFUSION; REPEATED MEASUREMENTS;

BLOOD;

CONTRAST MEDIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CADAVER; CONTRAST ENHANCEMENT; DILUTION; DOG; EQUIPMENT; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY PERFUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; THEORY; TIME SERIES ANALYSIS;

EID: 0037310235     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10380     Document Type: Article

References (29)

1. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-641.
2. Schreiber WG, Gückel F, Stritzke P, Schmiedek P, Schwartz A, Brix G. Cerebral blood flow and cerebrovascular reserve capacity: estimation by dynamic magnetic resonance imaging. J Cereb Blood Flow Metab 1998;18:1143-1156.
3. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. I. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
4. Østergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. II. Experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736.
5. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6:731-744.
6. Ahlström H, Johansson L, Ragnarsson A. Pulmonary MRA during continuous breathing using a blood pool agent and navigator echo. In: Proceedings of the 6th Annual Meeting of ISMRM, Sydney, Australia, 1998. p 170.
7. Aumann S, Schoenberg SO, Just A, Briley-Saebo K, Knopp MV, Brix G. Quantification of renal perfusion: results of an experimental animal study. In: Proceedings of the 7th Annual Meeting of ISMRM, Philadelphia, 1999. p 1857.
8. Schoenberg SO, Knopp MV, Bock M, Prince MR, Allenberg JR. Combined morphologic and functional assessment of renal artery stenosis using gadolinium enhanced magnetic resonance imaging. Nephrol Dial Transplant 1998;13:2738-2742.
9. Prasad PV, Cannillo J, Chavez DR, Pinchasin ES, Dolan RP. Walovitch R, Edelman RR. First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent. Invest Radiol 1999;34:566-571.
10. Knopp MV, Floemar F, Schoenberg So, Tengg-Kobligk H, Bock M, Wunsch C, Richter G, Hoffmann V, McGill S. Dose response analysis of a superparamagnetic contrast agent for MR angiography. Qualitative and quantitative in vivo assessment of Clariscan. In: Proceedings of the 8th Annual Meeting of ISMRM, Denver, 2000. p 1819.
11. Just A, Wittmann U, Ehmke H, Kirchheim HR. Autoregulation of renal blood flow in the conscious dog and the contribution of the tubuloglomerular feedback. J Physiol 1998;506:275-290.
12. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-566.
13. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
14. Zierler KL. Theoretical basis of indicator-dilution methods for measuring flow and volume. Circ Res 1965;16:393-407.
15. Axel L. Cerebral blood flow determination by rapid-sequence computed tomography. Radiology 1980;137:679-686.
16. Weisskoff RM, Chesler D, Boxermann JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;39:553-559.
17. Wirestam R, Andersson L, Østergaard L, Bolling M, Aunola JP, Lindgren A, Geijer B, Holtas S, Stahlberg F. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med 2000;43:691-700.
18. Stritzke P, King MA, Vaknine R, Goldsmith SJ. Deconvolution using orthogonal polynomials in nuclear medicine: a method for forming quantitative functional images from kinetic studies. IEEE Trans Med Imaging 1990;9:11-23.
19. Press WH, Teukolsky SA, Vetterling WT, Flummery BP. Numerical recipes. The art of scientific computing. Cambridge: Cambridge University Press; 1999.
20. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466-473.
21. Hierholzer K, Fromm M. Funktionen der Nieren. In: Schmidt RF, Thews G, editors. Physiologie des Menschen. Berlin, Heidelberg, New York: Springer; 1997. p 737-776.
22. Levin JM, Kaufman MJ, Ross MH, Mendelson JH, Maas LC, Cohen BM, Renshaw PF. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic pertubation. Magn Reson Med 1995;34:655-663.
23. Simonsen CZ, Østergaard L, Vestergaard-Poulsen P, Røhl L, Bjønerud A, Gyldensted C. CBF and CBV measurements by USPIO bolus tracking: reproducibility and comparison with Gd-based values. J Magn Reson Imaging 1999;9:342-347.
24. Bjørnerud A, Johansson LO, Ahlström H. T2*renal perfusion using NC100150 injection. Influence of T1-shortening on the first-pass response. In: Proceedings of the 8th Annual Meeting of ISMRM, Denver, 2000. p 731.
25. Johnson KM, Tao JZ, Kennan RP, Gore JC. Intravascular susceptibility agent effects on tissue transverse relaxation rates in vivo. Magn Reson Med 2000;44:909-914.
26. Prasad PV, Kim D, Kaiser AM, Chavez D, Gladstone S, Li W, Buxton RB, Edelman RR. Noninvasive comprehensive characterization of renal artery stenosis by combination of STAR angiography and EPISTAR perfusion imaging. Magn Reson Med 1997;8:776-787.
27. Williams DS, Zhang W, Koretsky AP, Adler S. Perfusion imaging of the rat kidney with MR. Radiology 1994;190:813-881.
28. Wang JJ, Hendrich KS, Jackson EK, Ildstad ST, Williams DS, Ho C. Perfusion quantitation in transplanted rat kidney by MRI with arterial spin labeling. Kidney Int 1998;53:1783-1791.
29. Karger N, Biederer J, Lusse S, Grimm J, Steffens J, Heller M, Gluer C. Quantitation of renal perfusion using arterial spin labeling with FAIR-UFLARE. Magn Reson Imaging 2000;18:641-647.